CYP3A4*22 and bleeding risk in ticagrelor users.

Asiimwe, Innocent G ORCID: 0000-0002-1196-1822 and Pirmohamed, Munir ORCID: 0000-0002-7534-7266 (2024) CYP3A4*22 and bleeding risk in ticagrelor users. Basic & clinical pharmacology & toxicology, 134 (3). pp. 311-314.

Text Basic Clin Pharma Tox - 2024 - Asiimwe - CYP3A4 22 and bleeding risk in ticagrelor users.pdf - Author Accepted Manuscript Available under License Creative Commons Attribution. Download (751kB) | Preview

Item Type:	Article
Uncontrolled Keywords:	Humans, Platelet Aggregation Inhibitors, Treatment Outcome, Cytochrome P-450 CYP3A, Acute Coronary Syndrome, Percutaneous Coronary Intervention, Clopidogrel, Ticagrelor
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	09 Jan 2024 11:23
Last Modified:	01 Mar 2024 16:17
DOI:	10.1111/bcpt.13977
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3177741